Small Science, Big Discoveries: How Biotech Startups Are Unlocking Hemp's Pharmaceutical Frontier While Big Pharma Looks Away
While pharmaceutical giants have largely sidestepped hemp-derived compounds due to regulatory uncertainty and thin profit projections, a growing constellation of biotech startups and university laboratories is methodically mining the plant's extraordinary chemical complexity. These smaller actors are surfacing novel cannabinoids and associated molecules with genuine therapeutic promise — and they are doing so with a fraction of the resources that major drug corporations command. The question now